53 results
8-K
EX-10.2
35f88fh6t6a k0tx8plm
19 Sep 22
Viracta Therapeutics’ Board of Directors appoints Mark Rothera as President and Chief Executive Officer
8:10am
8-K
EX-10.1
b3jf prgoltdvpm
19 Sep 22
Viracta Therapeutics’ Board of Directors appoints Mark Rothera as President and Chief Executive Officer
8:10am
424B3
2wsba5qxeynrk7j
14 Jan 21
Prospectus supplement
5:11pm
S-4/A
EX-10.22
qjprl8r1gh6 8tpen6
12 Jan 21
Registration of securities issued in business combination transactions (amended)
9:54pm
S-4/A
bg1hv 46z
12 Jan 21
Registration of securities issued in business combination transactions (amended)
9:54pm
S-4/A
EX-10.26
iv3f9f0i8emipn2u
12 Jan 21
Registration of securities issued in business combination transactions (amended)
9:54pm
S-4
f9r0c 9ccxf1fxz2
22 Dec 20
Registration of securities issued in business combination transactions
6:24am
S-4
EX-10.29
gc5223
22 Dec 20
Registration of securities issued in business combination transactions
6:24am